These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 32901872)
1. Downregulation of miR‑181b inhibits human colon cancer cell proliferation by targeting CYLD and inhibiting the NF‑κB signaling pathway. Yang X; Sun Y; Zhang Y; Han S Int J Mol Med; 2020 Nov; 46(5):1755-1764. PubMed ID: 32901872 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling. Xia JT; Chen LZ; Jian WH; Wang KB; Yang YZ; He WL; He YL; Chen D; Li W J Transl Med; 2014 Feb; 12():33. PubMed ID: 24495516 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD. Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739 [TBL] [Abstract][Full Text] [Related]
4. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD. Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382 [TBL] [Abstract][Full Text] [Related]
5. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD. Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway. Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061 [TBL] [Abstract][Full Text] [Related]
7. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer. Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473 [TBL] [Abstract][Full Text] [Related]
8. Research on mechanism of miR-130a in regulating autophagy of bladder cancer cells through CYLD. Dai H; Liu C; Liu Y; Zhang Z; Peng C; Wang Z; Zheng J; Li C; Yu W; Cheng F J BUON; 2020; 25(3):1636-1642. PubMed ID: 32862616 [TBL] [Abstract][Full Text] [Related]
9. miR‑181b‑p53 negative feedback axis regulates osteosarcoma cell proliferation and invasion. Wan J; Long F; Zhang C; Liu Y Int J Mol Med; 2020 Jun; 45(6):1803-1813. PubMed ID: 32236583 [TBL] [Abstract][Full Text] [Related]
10. miR-182 controls cell growth in gastrointestinal stromal tumors by negatively regulating CYLD expression. Ling T; Yu F; Cao H Oncol Rep; 2018 Dec; 40(6):3705-3713. PubMed ID: 30542706 [TBL] [Abstract][Full Text] [Related]
11. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades. Zhao G; Yin Y; Zhao B J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607 [TBL] [Abstract][Full Text] [Related]
12. miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer. Zheng Y; Zheng Y; Lei W; Xiang L; Chen M Mol Cell Probes; 2019 Dec; 48():101445. PubMed ID: 31513891 [TBL] [Abstract][Full Text] [Related]
13. Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells. La T; Jin L; Liu XY; Song ZH; Farrelly M; Feng YC; Yan XG; Zhang YY; Thorne RF; Zhang XD; Teng L Oncol Res; 2020 Sep; 28(4):385-398. PubMed ID: 32252875 [TBL] [Abstract][Full Text] [Related]
14. MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression. Liang HL; Hu AP; Li SL; Xie JP; Ma QZ; Liu JY Asian Pac J Cancer Prev; 2015; 16(6):2397-402. PubMed ID: 25824771 [TBL] [Abstract][Full Text] [Related]
15. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer. Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899 [TBL] [Abstract][Full Text] [Related]
16. miR-130b regulates B cell proliferation via CYLD-mediated NF-κB signaling. Wu M; Zhao J; Wu W; Hao C; Yang Y; Zhang J Exp Cell Res; 2024 Jan; 434(1):113870. PubMed ID: 38049082 [TBL] [Abstract][Full Text] [Related]
17. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer. Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996 [TBL] [Abstract][Full Text] [Related]
18. MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma. Zhi F; Wang Q; Deng D; Shao N; Wang R; Xue L; Wang S; Xia X; Yang Y PLoS One; 2014; 9(10):e109124. PubMed ID: 25299073 [TBL] [Abstract][Full Text] [Related]
19. MiR-155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis. Xu L; Leng H; Shi X; Ji J; Fu J; Leng H Biomed Pharmacother; 2017 Jun; 90():524-530. PubMed ID: 28402921 [TBL] [Abstract][Full Text] [Related]
20. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4. Fan Y; Wang K Mol Med Rep; 2020 Aug; 22(2):633-642. PubMed ID: 32467998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]